지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 한국응용약물학회 The journal of applied pharmacology : the official journal of the Korean Society of Applied Pharmacology The journal of applied pharmacology : the official journal of the Korean Society of Applied Pharmacology 제14권 제4호
- 발행연도
- 2006.1
- 수록면
- 189 - 193 (5page)
이용수
초록· 키워드
오류제보하기
This study was designed to assess the distribution of cytochrome P450 2E1 (CYP2E1) polymorphism among Korean patients on warfarin therapy. CYP2E1 polymorphism was analyzed at 5' flanking region of CYP2E1 gene using restriction fragment length polymorphism method. Patient characteristics including the measured internal normalized ratio (INR) were also evaluated. Based on the warfarin dose and the bleeding cases, the patients were grouped as the regular dose control, the regular dose bleeding, the low dose control, and the low dose bleeding. Total 96 patients were evaluated for both Pst I and Rsa I loci of the CYP2E1 gene and the results showed that both loci were tightly linked. Thirty-three patients(34.4%) were heterozygotes and 4 patients(4.2%) were homozygote. There was no significant difference in patient characteristics in the dose and bleeding case groups. CYP2E1 polymorphism showed a little difference among the groups but was not statistically significant, however, lower INR value was observed in homozygote genotype groups. It was also revealed that genotype allele frequencies of CYP2E1 in Korean was close to other Asian groups but was significantly different from other Caucasian and African-American populations.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
CYP2C19 Polymorphism in Korean Patients on Warfarin Therapy
Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea
2007 .01
-
Polymorphism in CYP2C9 as a Non-Critical Factor of Warfarin Dosage Adjustment in Korean Patients
Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea
2003 .01
-
The Genetic Analysis of CYP2C9 Polymorphism in a Korean Population
대한임상약리학회 학술대회
1998 .01
-
CYP2E15B, CYP2E16, CYP2E17B, CYP2E12, and CYP2E13 Allele Frequencies in Iranian Populations
Asian Pacific journal of cancer prevention : APJCP
2012 .01
-
Association of CYP2C19*2 and *3 Genetic Variants with Essential Hypertension in Koreans
Yonsei Medical Journal
2012 .01
-
CYP2E1과 CYP2C19 유전자 다형성이 위암 발생 감수성에 미치는 영향
Annals of Surgical Treatment and Research
2007 .08
-
Analysis of CYP17, CYP19 and CYP1A1 Gene Polymorphisms in Iranian Women with Breast Cancer
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Allele and genotype frequencies of CYP2B6 in Korean population
대한임상약리학회 학술대회
2002 .01
-
Four Polymorphisms in the Cytochrome P450 1A2 (CYP1A2) Gene and Lung Cancer Risk: a Meta-analysis
Asian Pacific journal of cancer prevention : APJCP
2014 .01
-
CYP2E1 Genetic Polymorphisms and Breast Cancer
대한외과학회 학술대회 초록집
2001 .11
-
Clinical Relevances of CYP2C9 Genetic Polymorphisms
대한임상약리학회 심포지움
2002 .01
-
한국인 여성에서 중증 자궁내막증의 발생 위험도와 CYP19 유전자 다형성과의 관련성에 관한 연구
대한불임학회지
2005 .01
-
No Association of Cytochrome P450-1B1 Gene Polymorphisms with Risk of Breast Cancer: an Egyptian Study
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Association of gastric cancer with cytochrome P450 2C19 single-nucleotide polymorphisms in Koreans
Oriental pharmacy and experimental medicine
2007 .01
-
CYP2W1, CYP4F11 and CYP8A1 Polymorphisms and Interaction of CYP2W1 Genotypes with Risk Factors in Mexican Women with Breast Cancer
Asian Pacific journal of cancer prevention : APJCP
2012 .01
-
CYP1A1 Genetic Polymorphisms and Risk for Esophageal Cancer: a Case-control Study in Central China
Asian Pacific journal of cancer prevention : APJCP
2013 .01
-
ALDH and CYP2E1 Single Nucleotide Polymorphism Distribution in korean
International Journal of Oral Biology
2006 .01
-
The Genetic Polymorphism of CYP2E1 in a Korean Healthy Subjects and Hepatocellular Carcinoma Patients
대한임상약리학회 학술대회
1997 .01
-
Effects of CYP1A2$^*$1C and CYP1A2$^*$1F Genotypes on the Activity and Inducibility of CYP1A2 Determined by Urinary Caffeine Metabolite Ratio in Koreans
Molecular & cellular toxicology
2007 .01
-
A Case of Intolerance to Warfarin Dosing in an Intermediate Metabolizer of CYP2C9
Yonsei Medical Journal
2005 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0